Pricing Log in Create free account

Abpro Holdings Inc. (ABPO) vs Karyopharm Therapeutics Inc. (KPTI)

Abpro Holdings Inc. and Karyopharm Therapeutics Inc. are both Biotechnology companies. Abpro Holdings Inc. and Karyopharm Therapeutics Inc. are of similar size ($1.4M and $1.4M). Karyopharm Therapeutics Inc. has negative trailing earnings, so its P/E is not meaningful; Abpro Holdings Inc. trades at 0.5×. Abpro Holdings Inc. has the higher net margin (0.00% vs −153.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Abpro Holdings Inc. leads on 7 and Karyopharm Therapeutics Inc. on 4.

Valuation

Metric ABPO KPTI Biotechnology median
P/E 0.55 n/m 10.60
P/S n/m 0.01 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.16 n/m 0.66
EV/Sales n/m 1.27 9.02
Earnings yield 183.50% (25,680.00%) (32.88%)
Free cash flow yield (193.29%) (4,526.16%) (23.13%)

Profitability

Metric ABPO KPTI Biotechnology median
Gross margin — 95.89% 68.51%
Operating margin 0.00% (56.17%) 0.00%
Net margin 0.00% (153.28%) 0.00%
Free cash flow margin 0.00% (44.57%) 0.00%
Return on equity (20.18%) 78.98% (51.96%)
Return on assets 46.10% (207.90%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ABPO KPTI Biotechnology median
Revenue growth (TTM) — 6.81% 6.76%
EPS growth (last fiscal year) 94.15% (28.07%) 29.88%
Revenue growth, 5-year CAGR — 6.21% 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ABPO KPTI Biotechnology median
Debt to equity 0.00 (0.76) 0.00
Current ratio 0.62 0.79 4.97
Net debt to EBITDA 0.01 (2.03) 1.01

Dividend

Metric ABPO KPTI Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ABPO KPTI Biotechnology median
Market cap 1.42m 1.36m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack